Goeasy: Well-Placed to Adapt to Potential Rate Change by Accelerating Strategy of Continously Reducing Weighted Average Interest Rate Charged to Borrowers; To Keep Expanding Products, Distribution Channels, Leveraging Risk-Based Pricing to Cut Borrowing Costs for Consumers;

Has Also Raised Senior Secured Revolving Credit Facility by C$100M to C$370M; Has Received Approval From Canadian Insurer for C$150M of Additional Financing;

Enhancements Complement Existing C$1.6B Revolving Securitization Warehouse Facilities, Will Be Used for General Purposes; Confident That Existing Funding Facilities, Ability to Raise Additional Debt Financing, Will Fund Organic Growth Targets

---

Sierra Metals 4Q Revenue From Metals Payable $46.2 M; 4Q Loss/Shr 16c; Special Committee Continues to Evaluate Certain Strategic Alternatives


Expected Major Events for Wednesday

06:00/GER: Apr GfK consumer climate survey

06:45/FRA: Feb Housing starts

06:45/FRA: Mar Consumer confidence survey

08:00/ITA: Feb Foreign Trade non-EU

08:30/UK: Feb Monetary & Financial Statistics

08:30/UK: Feb Bank of England effective interest rates

08:30/UK: Feb Money and Credit - Lending to Individuals, Lending to Businesses, Broad Money and Credit

11:00/US: 03/24 MBA Weekly Mortgage Applications Survey

12:30/US: 4Q U.S. International Investment Position

14:00/US: Feb Pending Home Sales Index

14:30/US: 03/24 EIA Weekly Petroleum Status Report

23:01/UK: Feb UK monthly automotive manufacturing figures

23:01/UK: Mar CBI Growth Indicator and Service Sector Survey

23:50/JPN: Mar Provisional Trade Statistics for 1st 10 days of Month

All times in GMT. Powered by Onclusive and Dow Jones.


Expected Earnings for Wednesday

Abraxas Petroleum (AXAS) is expected to report for 4Q.

Accelerate Diagnostics Inc (AXDX) is expected to report $-0.13 for 4Q.

Aerovate Therapeutics Inc (AVTE) is expected to report for 4Q.

Arlington Asset Investment Corp (AAIC) is expected to report $0.04 for 4Q.

Atreca Inc (BCEL) is expected to report for 4Q.

Avalo Therapeutics Inc (AVTX) is expected to report for 4Q.

Axcella Health Inc (AXLA) is expected to report for 4Q.

Cathedral Energy Services is expected to report for 4Q.

Cintas Corp (CTAS) is expected to report $2.99 for 3Q.

Clovis Oncology Inc (CLVSQ) is expected to report $-1.72 for 4Q.

Codiak BioSciences Inc (CDAK) is expected to report for 4Q.

Conn's (CONN) is expected to report $-0.88 for 4Q.

Constellation Software is expected to report $6.25 for 4Q.

Dollarama (DLMAF,DOL.T) is expected to report $0.88 for 4Q.

Excellon Resources is expected to report for 4Q.

GlycoMimetics Inc (GLYC) is expected to report $-0.17 for 4Q.

Lightbridge Corp (LTBR) is expected to report for 4Q.

Local Bounti Corp (LOCL) is expected to report for 4Q.

Lyra Therapeutics Inc (LYRA) is expected to report for 4Q.

Microbot Medical Inc (MBOT) is expected to report for 4Q.

Neptune Wellness Solutions Inc (NEPT,NEPT-T) is expected to report for 3Q.

NexImmune Inc (NEXI) is expected to report for 4Q.

Odyssey Marine Exploration Inc (OMEX) is expected to report for 4Q.

Oncocyte Corp (OCX) is expected to report $-0.09 for 4Q.

Paychex Inc (PAYX) is expected to report $1.24 for 3Q.

Pieris Pharmaceuticals Inc (PIRS) is expected to report $-0.21 for 4Q.

Professional Diversity Network Inc (IPDN) is expected to report for 4Q.

ReShape Lifesciences Inc (RSLS) is expected to report for 4Q.

Reading International Inc (RDI) is expected to report $0.10 for 4Q.

Security National Financial Corp (SNFCA) is expected to report for 4Q.

Semtech (SMTC) is expected to report $0.27 for 4Q.

Sharecare Inc (SHCR) is expected to report for 4Q.

Tattooed Chef Inc (TTCF) is expected to report for 4Q.

Telesat Corp (TSAT) is expected to report for 4Q.

TuSimple Holdings Inc (TSP) is expected to report for 4Q.

US Global Investors (GROW) is expected to report for 2Q.

UniFirst Corp (UNF) is expected to report $1.02 for 2Q.

Vyant Bio Inc (VYNT) is expected to report for 4Q.

bluebird bio Inc (BLUE) is expected to report $-0.38 for 4Q.

iSign Solutions Inc (ISGN) is expected to report for 4Q.

Powered by Onclusive and Dow Jones.


ANALYST RATINGS ACTIONS

Adobe Raised to Buy From Hold by Erste Group

Applied Molecular Trnsprt Cut to Neutral From Buy by Chardan Capital

Array Technologies Raised to Buy From Hold by Truist Securities

Carnival Raised to Equal-Weight From Underweight by Wells Fargo

Ciena Raised to Strong Buy From Outperform by Raymond James

Coherus BioSciences Raised to Buy From Neutral by UBS

Easterly Govt Properties Raised to Buy From Neutral by Compass Point

Elevance Health Raised to Outperform From Sector Perform by RBC Capital

Encore Capital Group Raised to Buy From Neutral by Janney Montgomery Scott

FactSet Research Raised to Neutral From Sell by Redburn Partners

Fox Corp. Cut to Neutral From Buy by B of A Securities

Genesco Raised to Buy From Neutral by Seaport Global

iHeartMedia Cut to Underperform From Neutral by B of A Securities

Marathon Petroleum Cut to Neutral From Overweight by JP Morgan

NextEra Energy Raised to Buy From Hold by Erste Group

Occidental Petroleum Raised to Outperform From Market Perform by TD Cowen

Paramount Global Raised to Buy From Neutral by B of A Securities

Parsons Raised to Outperform From Market Perform by William Blair

TD SYNNEX Cut to Hold From Buy by CFRA

Venus Concept Cut to Hold From Buy by Maxim Group

Walmart Cut to Hold From Buy by Erste Group

This article is a text version of a Wall Street Journal newsletter published earlier today.


(END) Dow Jones Newswires

03-29-23 0613ET